Doctor profile · Federal record

Dr. Morgan Bittengle

Family Nurse Practitioner (CMS: Nurse Practitioner) · Little Rock, AR

  • NPI 1417587239
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 7 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
800 Fair Park Blvd
Little Rock, AR 722041720
(501) 404-8007
fax (501) 904-3620
Mailing address
5800 W 10Th St Ste 610
Little Rock, AR 722041772

Credentials & registration

NPPES · NUCC
NPI registered
January 2020 — 6 yrs on file
Profile last updated
January 17, 2024
Year of graduation
2019 — 7 yrs since
Specialty taxonomy
363LF0000X — NUCC code
State license (1)
Arkansas #0

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1417587239. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
19,190
Distinct HCPCS
10
Medicare allowed
$509,080
HCPCS Description Services Patients Avg allowed
J1602 Injection, golimumab, 1 mg, for intravenous use 6,600 11 $13
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg 3,395 19 $35
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 3,225 11 $42
J0897 Injection, denosumab, 1 mg 2,520 34 $23
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 908 93 $1
99213 Established patient office or other outpatient visit, 20-29 minutes 429 297 $68
99214 Established patient office or other outpatient visit, 30-39 minutes 397 265 $94
86235 Measurement of antibody for assessment of autoimmune disorder, any method 357 41 $17
96372 Injection of drug or substance under skin or into muscle 197 64 $11
96415 Administration of chemotherapy into vein, each additional hour 145 41 $21

In context: peer comparison

Among 84 peers in Little Rock Family Nurse Practitioner, average services per provider: 204. This provider delivers 94× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,031
Transactions
73
Manufacturers
10
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 28 $448.15
Amgen INC. 35 $390.16
Lilly USA, LLC 2 $39.42
Ucb, INC. 2 $35.94
E.R. Squibb & Sons, L.L.C. 1 $24.08
GlaxoSmithKline, LLC. 1 $22.54
Janssen Biotech, INC. 1 $21.95
Fresenius Kabi USA, LLC 1 $17.65
Pacira Pharmaceuticals Incorporated 1 $15.67
Pfizer INC. 1 $15.27

By nature of payment

Food and Beverage
$1,031

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
5,338
Patients
1,529
Total drug cost
$214,067
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 1,115 298 $66,324
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 625 157 $19,631
Gabapentin Generic 515 145 $10,030
Prednisone Generic 464 167 $4,176
Methotrexate (Methotrexate Sodium) Brand 446 127 $15,983
Diclofenac Sodium Generic 380 121 $10,631
Sulfasalazine Generic 305 90 $5,798
Tramadol Hcl Generic 301 82 $3,375
Colchicine Generic 294 94 $35,855
Leflunomide Generic 265 71 $18,109

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Morgan Bittengle's medical specialty?
Dr. Morgan Bittengle practices Family Nurse Practitioner in Little Rock, AR.
Where does Dr. Morgan Bittengle practice?
Dr. Morgan Bittengle practices at 800 Fair Park Blvd, Little Rock, AR 722041720. Office phone: 5014048007.
What is Dr. Morgan Bittengle's NPI?
Dr. Morgan Bittengle's National Provider Identifier (NPI) is 1417587239, issued by NPPES.
Does Dr. Morgan Bittengle accept Medicare assignment?
Yes. Dr. Morgan Bittengle accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Morgan Bittengle commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (HCPCS Q5104); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.